Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

17.43
Delayed Data
As of Aug 26
 +0.09 / +0.52%
Today’s Change
9.45
Today|||52-Week Range
18.70
+3.44%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 19.50, with a high estimate of 25.00 and a low estimate of 18.00. The median estimate represents a +11.88% increase from the last price of 17.43.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$32.1M
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.36%
 
 
 
 
 
 
Growthannually -75.68%
 
 
 
 
 
 

Sales

Growthquarterly -2.02%
 
 
 
 
 
 
Growthannually -27.93%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.